Heather Elisa Olson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 25 | 2024 | 305 | 7.970 |
Why?
|
Epilepsy | 23 | 2023 | 3310 | 2.730 |
Why?
|
Epilepsy, Generalized | 5 | 2023 | 174 | 1.690 |
Why?
|
Seizures, Febrile | 4 | 2022 | 111 | 1.510 |
Why?
|
Anticonvulsants | 9 | 2023 | 1916 | 1.230 |
Why?
|
Rett Syndrome | 5 | 2024 | 165 | 1.180 |
Why?
|
Pregnanolone | 2 | 2023 | 62 | 1.100 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2023 | 49 | 0.940 |
Why?
|
Fenfluramine | 1 | 2021 | 59 | 0.820 |
Why?
|
KCNQ2 Potassium Channel | 2 | 2023 | 24 | 0.820 |
Why?
|
Epilepsies, Myoclonic | 1 | 2021 | 80 | 0.780 |
Why?
|
Vision Disorders | 5 | 2023 | 1058 | 0.730 |
Why?
|
Status Epilepticus | 3 | 2023 | 444 | 0.730 |
Why?
|
Evoked Potentials, Visual | 2 | 2023 | 427 | 0.700 |
Why?
|
Malformations of Cortical Development | 2 | 2021 | 200 | 0.690 |
Why?
|
Facies | 2 | 2018 | 197 | 0.640 |
Why?
|
Vision, Ocular | 1 | 2021 | 464 | 0.620 |
Why?
|
Visual Pathways | 1 | 2021 | 565 | 0.570 |
Why?
|
Seizures | 12 | 2023 | 2859 | 0.550 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2017 | 93 | 0.550 |
Why?
|
Cerebellar Diseases | 1 | 2018 | 226 | 0.540 |
Why?
|
Chorea | 2 | 2020 | 74 | 0.530 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 377 | 0.520 |
Why?
|
Phenotype | 14 | 2022 | 16365 | 0.510 |
Why?
|
Child, Preschool | 27 | 2024 | 41006 | 0.500 |
Why?
|
Frameshift Mutation | 2 | 2023 | 399 | 0.490 |
Why?
|
Movement Disorders | 4 | 2023 | 445 | 0.490 |
Why?
|
Spasm | 3 | 2023 | 121 | 0.480 |
Why?
|
Hemiplegia | 1 | 2014 | 135 | 0.470 |
Why?
|
Developmental Disabilities | 4 | 2020 | 1456 | 0.440 |
Why?
|
Genes, Duplicate | 1 | 2012 | 33 | 0.420 |
Why?
|
Chromosome Disorders | 1 | 2014 | 514 | 0.390 |
Why?
|
Triage | 1 | 2017 | 976 | 0.380 |
Why?
|
Mutation, Missense | 3 | 2020 | 2564 | 0.370 |
Why?
|
Infant | 22 | 2024 | 35136 | 0.370 |
Why?
|
Encephalitis | 2 | 2013 | 423 | 0.370 |
Why?
|
Electroencephalography | 11 | 2023 | 6150 | 0.360 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 658 | 0.340 |
Why?
|
Triazoles | 2 | 2014 | 911 | 0.340 |
Why?
|
Schwann Cells | 1 | 2009 | 195 | 0.320 |
Why?
|
Polyglycolic Acid | 1 | 2009 | 407 | 0.310 |
Why?
|
Cranial Sinuses | 2 | 2017 | 66 | 0.300 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 1941 | 0.290 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2017 | 356 | 0.240 |
Why?
|
Humans | 58 | 2024 | 744343 | 0.240 |
Why?
|
Child | 25 | 2024 | 77709 | 0.240 |
Why?
|
Lactic Acid | 1 | 2009 | 1133 | 0.240 |
Why?
|
Genetic Testing | 5 | 2022 | 3444 | 0.230 |
Why?
|
Vigabatrin | 1 | 2023 | 92 | 0.220 |
Why?
|
Brain Diseases | 3 | 2023 | 1563 | 0.210 |
Why?
|
Genetic Association Studies | 5 | 2022 | 2703 | 0.200 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 931 | 0.200 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2023 | 648 | 0.190 |
Why?
|
Cyclin D2 | 1 | 2021 | 101 | 0.190 |
Why?
|
Axons | 1 | 2009 | 1684 | 0.190 |
Why?
|
Male | 33 | 2023 | 350118 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 4 | 2021 | 17446 | 0.190 |
Why?
|
Biocompatible Materials | 1 | 2009 | 1736 | 0.190 |
Why?
|
Polydactyly | 1 | 2021 | 57 | 0.190 |
Why?
|
Munc18 Proteins | 2 | 2022 | 29 | 0.180 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2023 | 671 | 0.180 |
Why?
|
Drugs, Investigational | 1 | 2021 | 214 | 0.170 |
Why?
|
Ultrasonography, Prenatal | 2 | 2017 | 1695 | 0.170 |
Why?
|
Female | 33 | 2023 | 380194 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 89 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7659 | 0.160 |
Why?
|
Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2017 | 10 | 0.160 |
Why?
|
Aspartate-Ammonia Ligase | 1 | 2017 | 16 | 0.160 |
Why?
|
Hospitalization | 1 | 2017 | 10262 | 0.160 |
Why?
|
Sodium Channels | 1 | 2020 | 349 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 449 | 0.150 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.150 |
Why?
|
Age of Onset | 3 | 2020 | 3271 | 0.150 |
Why?
|
Levodopa | 1 | 2017 | 219 | 0.140 |
Why?
|
Neurons | 2 | 2022 | 9338 | 0.140 |
Why?
|
Mutation | 7 | 2023 | 29786 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.140 |
Why?
|
Cannabinoids | 1 | 2019 | 166 | 0.140 |
Why?
|
Receptors, GABA-A | 1 | 2020 | 627 | 0.140 |
Why?
|
Stem Cells | 1 | 2009 | 3567 | 0.140 |
Why?
|
Adolescent | 14 | 2024 | 85781 | 0.140 |
Why?
|
Vagus Nerve Stimulation | 1 | 2019 | 199 | 0.130 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 145 | 0.130 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39050 | 0.130 |
Why?
|
Angelman Syndrome | 1 | 2017 | 136 | 0.130 |
Why?
|
Medulloblastoma | 1 | 2021 | 683 | 0.130 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2017 | 255 | 0.130 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 895 | 0.130 |
Why?
|
Infant, Newborn | 4 | 2020 | 25625 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2021 | 748 | 0.120 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 315 | 0.120 |
Why?
|
Corpus Callosum | 1 | 2019 | 737 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2023 | 63114 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1855 | 0.120 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2014 | 67 | 0.120 |
Why?
|
Alternative Splicing | 1 | 2019 | 1117 | 0.110 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2015 | 191 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2023 | 1613 | 0.110 |
Why?
|
Young Adult | 11 | 2024 | 56430 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 719 | 0.110 |
Why?
|
Double-Blind Method | 2 | 2023 | 12026 | 0.110 |
Why?
|
Genotype | 4 | 2023 | 12951 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3597 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15540 | 0.100 |
Why?
|
Models, Molecular | 2 | 2019 | 5456 | 0.100 |
Why?
|
Epilepsies, Partial | 1 | 2015 | 436 | 0.100 |
Why?
|
Heterozygote | 1 | 2018 | 2804 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.100 |
Why?
|
Protein Conformation | 1 | 2019 | 4011 | 0.100 |
Why?
|
Trisomy | 1 | 2012 | 266 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1170 | 0.090 |
Why?
|
Sodium Channel Blockers | 2 | 2022 | 176 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2022 | 2958 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1736 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2014 | 867 | 0.080 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1775 | 0.080 |
Why?
|
Cell Shape | 1 | 2009 | 375 | 0.080 |
Why?
|
Boston | 2 | 2017 | 9313 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2023 | 4462 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18029 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3920 | 0.070 |
Why?
|
Patient Compliance | 1 | 2014 | 2684 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2009 | 2726 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6103 | 0.060 |
Why?
|
Nerve Regeneration | 1 | 2009 | 788 | 0.060 |
Why?
|
Psychometrics | 2 | 2024 | 3002 | 0.060 |
Why?
|
Failure to Thrive | 1 | 2023 | 136 | 0.050 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 956 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2023 | 165 | 0.050 |
Why?
|
Athetosis | 1 | 2020 | 16 | 0.050 |
Why?
|
Biopsy | 1 | 2013 | 6756 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 35421 | 0.050 |
Why?
|
Animals | 8 | 2020 | 168757 | 0.050 |
Why?
|
Adult | 8 | 2024 | 214055 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.050 |
Why?
|
Dextromethorphan | 1 | 2020 | 38 | 0.050 |
Why?
|
Motor Skills | 1 | 2024 | 522 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1620 | 0.050 |
Why?
|
Anesthesia | 1 | 2011 | 1561 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2019 | 21746 | 0.040 |
Why?
|
Memantine | 1 | 2020 | 100 | 0.040 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2019 | 17 | 0.040 |
Why?
|
Cell Survival | 1 | 2009 | 5882 | 0.040 |
Why?
|
Pyridoxal Phosphate | 1 | 2019 | 127 | 0.040 |
Why?
|
Pyridoxine | 1 | 2019 | 102 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2925 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.040 |
Why?
|
Gene Duplication | 1 | 2020 | 329 | 0.040 |
Why?
|
Ataxia | 1 | 2020 | 304 | 0.040 |
Why?
|
Patch-Clamp Techniques | 1 | 2020 | 964 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4186 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14722 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8301 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12959 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9438 | 0.040 |
Why?
|
Asparagine | 1 | 2017 | 122 | 0.040 |
Why?
|
Speech Disorders | 1 | 2019 | 189 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2020 | 457 | 0.040 |
Why?
|
Vitamin B 6 | 1 | 2019 | 237 | 0.040 |
Why?
|
Dystonia | 1 | 2020 | 363 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 40561 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2023 | 1056 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 173 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2020 | 957 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2020 | 767 | 0.040 |
Why?
|
Brain | 4 | 2022 | 26385 | 0.030 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 257 | 0.030 |
Why?
|
Survival Analysis | 1 | 2009 | 10252 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 778 | 0.030 |
Why?
|
United States | 1 | 2024 | 69872 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2017 | 293 | 0.030 |
Why?
|
Consanguinity | 1 | 2017 | 454 | 0.030 |
Why?
|
Oocytes | 1 | 2020 | 1187 | 0.030 |
Why?
|
Channelopathies | 1 | 2015 | 32 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 496 | 0.030 |
Why?
|
Glutamine | 1 | 2017 | 578 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 19905 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.030 |
Why?
|
Arginine | 1 | 2017 | 944 | 0.030 |
Why?
|
Genetic Variation | 2 | 2020 | 6544 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 19229 | 0.030 |
Why?
|
Siblings | 1 | 2017 | 854 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1785 | 0.030 |
Why?
|
Rats | 1 | 2009 | 24260 | 0.030 |
Why?
|
Cannabis | 1 | 2019 | 439 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
Caregivers | 1 | 2023 | 2094 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2015 | 600 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2019 | 4043 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 636 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 72290 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Cerebellum | 1 | 2016 | 1488 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6114 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4644 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2014 | 981 | 0.020 |
Why?
|
Coma | 1 | 2011 | 475 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8089 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 2994 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4161 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7799 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 6993 | 0.020 |
Why?
|
Calcium | 1 | 2017 | 5756 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6489 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
Autoantibodies | 1 | 2011 | 2035 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81183 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29144 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40075 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 213383 | 0.000 |
Why?
|